高级检索
当前位置: 首页 > 详情页

p21 protects cardiomyocytes against ischemia-reperfusion injury by inhibiting oxidative stress

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Emergency Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029 [2]Department of Cardiology, Beijing Hospital, Beijing 100730 [3]Department of Cardiology, The First Affiliated Hospital,Kunming Medical University, Kunming, Yunnan 650032, P.R. China
出处:
ISSN:

关键词: ischemia-reperfusion injury cyclin dependent kinase inhibitor 1A oxidative stress cardiomyocyte NF-E2-related factor-2 tumor protein p53

摘要:
Ischemic heart disease is a major health threat, resulting in a large number of mortalities annually worldwide. Oxidative stress is one of the main causes of cell death during ischemia-reperfusion (IR) injury. Cyclin dependent kinase inhibitor 1A (known as p21) is important in protecting tissues against IR injury, however the mechanism remains unknown. In the present study, oxygen-glucose deprivation and subsequent reoxygenation (OGD/R) in H9c2 heart-derived myocytes was used as a model to study myocardial IR injury in vitro. mRNA and protein expression levels were determined by reverse transcription-quantitative polymerase chain reaction and western blotting, respectively. The levels of reactive oxygen species were measured using the fluorescence dye 2,7-dichlorodihydrofluorescein diacetate. The present data demonstrated that p21 expression was upregulated by tumor protein p53 (p53) in H9c2 cells exposed to OGD/R. p21 protected H9c2 cells against OGD/R-induced oxidative stress. In addition, p21 mediated upregulation of NF-E2-related factor-2 (Nrf2), a regulator of antioxidant responses, which in turn suppressed cell death in H9c2 cells subjected to OGD/R. Thus, activation of the p53/p21/Nrf2 signaling pathway may be an important adaptive response that limits oxidative injury during IR.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
JCR分区:
出版当年[2017]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY Q2 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Department of Emergency Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029
共同第一作者:
通讯作者:
通讯机构: [2]Department of Cardiology, Beijing Hospital, Beijing 100730 [3]Department of Cardiology, The First Affiliated Hospital,Kunming Medical University, Kunming, Yunnan 650032, P.R. China [*1]Department of Cardiology, The First Affiliated Hospital, Kunming Medical University, 295 Xichang Road, Kunming, Yunnan 650032, P.R. China [*2]Department of Cardiology, The First Affiliated Hospital, Kunming Medical University, 295 Xichang Road, Kunming, Yunnan 650032, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82182 今日访问量:0 总访问量:679 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号